Home › Urothelial (Transitional Cell) Carcinoma › South Dakota
Urothelial (Transitional Cell) Carcinoma clinical trials in South Dakota
3 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in South Dakota.
Cities in South Dakota
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
- Avera Cancer Institute-Aberdeen, Aberdeen
- Avera Cancer Institute - Mitchell, Mitchell
- Avera Cancer Institute at Pierre, Pierre
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06524544A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Avera Medical Group, Sioux Falls
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06270706A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Avera Cancer Institute- Research, Sioux Falls
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07218380From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.